Pawan Kushwaha

Pawan Kushwaha

Director Director DIN 07554357
DIN 07554357 First appointment Jul 2016 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2016
Shareholding value Locked Premium profile

About Pawan Kushwaha

Pawan Kushwaha has 10 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 07554357
Primary Designation Director
First Appointment 28 Jul 2016
Oldest Company Age 10 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Bio Xenica Pharmaceuticals Private Limited U74999UP2016PTC085235
Director 28 Jul 2016 2016 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bio Xenica Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pawan Kushwaha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Kushwaha

Pawan Kushwaha has 10 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Pawan Kushwaha is associated with 0 companies as Director.

Pawan Kushwaha has expertise in General Business.

Pawan Kushwaha has 10 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available